Introduction
In lymphoproliferative neoplasms including chronic lymphocytic leukemia (CLL), hairy cell leukemia and even multiple myeloma, the biology of the monoclonal cells as well as the surrounding cells which are called microenvironment of the bone marrow are known to be in an interplay. Before the understanding of the importance of microenvironment, these malignancies were treated with cytotoxic agents which are aimed towards the actively DNA replicating cells. As the low grade lymphoproliferative malignancies replicate much slower, these agents generally did not achieve an adequate response despite their heavy treatment related burdens like toxicities. The need to treat slow replicating tumors led to other objectives, like targeted treatments for specific mutations and the modulation and even education of the microenvironment, making the immune system develop an anti-tumor response. This idea has led to genetic engineering and the development of chimeric antigen receptor (car) t-cell therapies which the future of hematology now depends. In this perspective, we aimed to investigate the innate immune response to CLL as well as the additional properties these monoclonal B-CLL cells may have acquired during the course of the disease and their implications on prognosis, complications and survival.
Materials and Methods
Data of 275 patients diagnosed with B-CLL were collected in a retrospective manner. Demographic features, laboratory including flow cytometry, immunoglobulins, genetic evaluations and clinical follow up were recorded from files. Flow cytometric analysis was performed on bone marrow samples at the time of diagnosis with Becton Dickenson (BD FACSCalibur platform) analyzer. Four color flow cytometric analysis has been used with fluoroscein isothiocyanate (FITC), R-phycoeryhtrin (PE), (Table 1) . ITP, lowIgG levels, high percentage of bone marrow infiltration, Richter's transformation were significantly corelated with CD8 positive microenvironment (p levels; 0.000; 0.000; 0.004; 0.000; 0.000 respectively) while AHA, development of secondary malignancies, hemoglobin and peripheral lymphocyte levels were not (Table 2) . Kaplan Meier analysis showed that CD8 expression on monoclonal cells was not related with survival while CD8+ T lymphocyte richness in the microenvironment was significantly related with survival ( Figure 2 and 3 ).
Discussion
Cancer is related with immunodefiency. With the evolution of tumors, they find ways to elude immune recognition (1) . The complex scheme used by tumoral cells to breakout from immune response include the production of proinflammatory cytokines, modulation of regulatory T cells (Tregs) and recruitment of tumor-associated macrophages (TAMs) (2, 3) . With the perspective of undoing the immune escape of tumors, reconstruction of immunomodulation has now found its place in the treatment of various hematological malignancies as wells as benign disorders like ITP. B-cell CLL is characterized by the slow accumulation of lymphocytes with mature appearance. Their long term presence in bone marrow and circulation is an example of tumor cells escaping immune recognition. In regardless of disease progression, CLL is strongly associated with immune dysregulation, both as an immune suppression also as an immune over reaction (4, 5) . Abnormalities related with T-cell mediated immunity and adaptive responses are now accepted as common and typical features of CLL (6) . Certain subsets of lymphocytes have been investigated in the immunosuppression of CLL. In 1970, Gershon et al have suggested the role of thymic lymphocytes in the cell interaction of immune tolerance (7) 
